Aleksandra Łacko

934 total citations
41 papers, 298 citations indexed

About

Aleksandra Łacko is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Aleksandra Łacko has authored 41 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Aleksandra Łacko's work include Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Aleksandra Łacko is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Aleksandra Łacko collaborates with scholars based in Poland, Hungary and United States. Aleksandra Łacko's co-authors include Rafał Matkowski, Iwona Gisterek, Jan Kornafel, Elżbieta Senkus, Jolanta Szelachowska, Agnieszka Hałoń, Marek Pudełko, B. Szynglarewicz, Sanjay Awasthi and Jyotsana Singhal and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Aleksandra Łacko

30 papers receiving 293 citations

Peers

Aleksandra Łacko
Jacob Smigiel United States
Jian Yuan Goh Singapore
Autumn L. Jackson United States
Corinna U. Brehm Germany
Tongmei Zhang China
Teming Zhang China
Ya-Ming Meng China
Tomitaro Onoue Japan
Steven M.J. Bradbury United Kingdom
Daniela I. Paiva‐Oliveira Portugal
Jacob Smigiel United States
Aleksandra Łacko
Citations per year, relative to Aleksandra Łacko Aleksandra Łacko (= 1×) peers Jacob Smigiel

Countries citing papers authored by Aleksandra Łacko

Since Specialization
Citations

This map shows the geographic impact of Aleksandra Łacko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleksandra Łacko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleksandra Łacko more than expected).

Fields of papers citing papers by Aleksandra Łacko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aleksandra Łacko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleksandra Łacko. The network helps show where Aleksandra Łacko may publish in the future.

Co-authorship network of co-authors of Aleksandra Łacko

This figure shows the co-authorship network connecting the top 25 collaborators of Aleksandra Łacko. A scholar is included among the top collaborators of Aleksandra Łacko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aleksandra Łacko. Aleksandra Łacko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Püsküllüoğlu, Mirosława, Anna Polakiewicz-Gilowska, Iveta Selingerová, et al.. (2025). 566P Effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer: A real-world retrospective cohort study from central Europe. Annals of Oncology. 36. S419–S419.
2.
3.
Püsküllüoğlu, Mirosława, Manuela Las‐Jankowska, Joanna Streb, et al.. (2024). Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort Study. Oncology and Therapy. 12(4). 787–801. 2 indexed citations
4.
Jarząb, Michał, Aleksandra Łacko, Bogumiła Czartoryska-Arłukowicz, et al.. (2024). The utility of the 21-gene Oncotype DX Breast Recurrence Score® assay in node-negative breast cancer patients – the final analysis of the Polish real life survey PONDx. Współczesna Onkologia. 28(3). 245–252.
5.
Duchnowska, Renata, Jolanta Smok-Kalwat, Katarzyna Pogoda, et al.. (2024). Real-world treatment outcomes in patients with HR+ HER2- advanced breast cancer treated with CDK4/6 inhibitors and endocrine therapy.. Journal of Clinical Oncology. 42(16_suppl). 1067–1067. 1 indexed citations
6.
7.
8.
Borštnar, Simona, Markéta Palácová, Aleksandra Łacko, et al.. (2022). Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial. Radiology and Oncology. 56(2). 238–247. 2 indexed citations
9.
Senkus, Elżbieta, Maria João Cardoso, Orit Kaidar‐Person, et al.. (2021). De-escalation of axillary irradiation for early breast cancer – Has the time come?. Cancer Treatment Reviews. 101. 102297–102297. 11 indexed citations
10.
Kunc, Michał, Marta Popęda, Anna Szałkowska, et al.. (2020). microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study. Diagnostics. 10(9). 617–617. 8 indexed citations
11.
Płużański, Adam, et al.. (2016). Prevention of chemotherapy-induced nausea and vomiting — standards versus clinical practice. Oncology in Clinical Practice. 12(4). 153–157. 1 indexed citations
12.
Senkus, Elżbieta & Aleksandra Łacko. (2016). Over-treatment in metastatic breast cancer. The Breast. 31. 309–317. 24 indexed citations
13.
Łacko, Aleksandra. (2012). Specificities of the treatment in elderly cancer patients. Oncology in Clinical Practice. 8(1). 1–6. 1 indexed citations
14.
Łacko, Aleksandra, et al.. (2011). Molecular predictive markers in the treatment of colorectal cancer with monoclonal antibodies targeting the epidermal growth factor receptor (EGFR). Oncology in Clinical Practice. 7(4). 224–229.
15.
Gisterek, Iwona, Rafał Matkowski, Agnieszka Hałoń, et al.. (2010). Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma.. Folia Histochemica et Cytobiologica. 48(1). 78–83. 4 indexed citations
16.
Matkowski, Rafał, Iwona Gisterek, Agnieszka Hałoń, et al.. (2009). The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.. PubMed. 29(7). 2445–51. 96 indexed citations
17.
Gisterek, Iwona, Rafał Matkowski, Aleksandra Łacko, et al.. (2009). Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors. Pathology & Oncology Research. 16(3). 337–344. 28 indexed citations
18.
Szynglarewicz, B., Rafał Matkowski, Agnieszka Hałoń, et al.. (2009). Association Between Histological Type of Tumour Growth and Patient Survival in T2-T3 Lymph Node-Negative Rectal Cancer Treated with Sphincter-Preserving Total Mesorectal Excision. Pathology & Oncology Research. 16(2). 201–206. 1 indexed citations
19.
Gisterek, Iwona, et al.. (2007). Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy. American Journal of Otolaryngology. 28(2). 73–77. 9 indexed citations
20.
Singhal, Sharad S., Jyotsana Singhal, Maya Nair, Aleksandra Łacko, & Sanjay Awasthi. (2007). Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. International Journal of Oncology. 30(3). 717–25. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob Smigiel Breakdown of academic impact, for papers by Jian Yuan Goh Breakdown of academic impact, for papers by Autumn L. Jackson Breakdown of academic impact, for papers by Corinna U. Brehm Breakdown of academic impact, for papers by Tongmei Zhang Breakdown of academic impact, for papers by Teming Zhang Breakdown of academic impact, for papers by Ya-Ming Meng Breakdown of academic impact, for papers by Tomitaro Onoue Breakdown of academic impact, for papers by Steven M.J. Bradbury Breakdown of academic impact, for papers by Daniela I. Paiva‐Oliveira
Rankless by CCL
2026